A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to ...

The NHS is launching a search for nearly 150,000 volunteers to take part in a series of research trials that could transform cancer treatment. Three cancer projects have been selected as part of the ...

To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a ...

The IDEAL team will test this new model on targets known to be relevant in ovarian cancer, the deadliest of gynecologic ...

Australia is on the brink of a healthcare revolution driven by DNA science that will save lives and prevent disease – but top ...

Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

Peter Ellis, 69, from Manchester tells us about his experience finding out he had prostate cancer after an unlucky golf ...

In a small subset of those patients, the combination resulted in a strong response with tumor shrinkage and no disease ...

Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.

Researchers have created a groundbreaking antibody that combines targeting, delivery, and immune activation to treat cancer, ...

In the UK, most prostate cancers are diagnosed in men aged 75–79, but rates rise steeply from 45–49. Black men are also more ...